Using tDCS as an Add-On Treatment Prior to FES Therapy in Improving Upper Limb Function in Severe Chronic Stroke Patients

A Randomized Controlled Study

Nuerjiayi Shaheiwola, Bin Zhang, Jie Jia, Dingguo Zhang

Research output: Contribution to journalArticle

2 Citations (Scopus)

Abstract

Background: Upper limb function recovery is of vital importance for stroke patients. However, it is difficult to get ideal recovery, especially for patients with severe chronic stroke. As the first randomized controlled long-term trial combining bilateral transcranial direct current stimulation (tDCS) and functional electrical stimulation (FES) therapy, this study examined the efficacy of a novel protocol that included applying tDCS as an add-on treatment prior to FES therapy over the course of a 4-week program. Methods: Thirty subjects with severe chronic stroke were randomized to either Group A (active tDCS+FES) ( N = 15) or Group B (sham tDCS+FES) ( N = 15). Five assessments including 3 behavioral outcome measurement scales [the Fugl-Meyer scale (cFMA), the Wolf motor function test (WMFT) and the modified Ashworth scale (MAS)], the surface electromyography (sEMG) evaluation and the transcranial magnetic stimulation (TMS) assessment were performed to evaluate subjects before and after the overall therapy. Results: In Group A, the combined protocol was well tolerated by all patients and induced significant improvements in upper extremity motor abilities in terms of the assessments of cFMA [ t (14) = -5.658, p < 0.05], WMFT [ t (14) = -3.746, p < 0.05], MAS [ t (14) = 5.236, p < 0.05], sEMG and TMS. The results of between-group comparisons showed there was a significant difference between Group A and Group B in terms of the assessments of cFMA [ t (28) = 2.223, p < 0.05], WMFT [ t (28) = -2.152, p < 0.05] and sEMG [ F (1, 196) = 0.918, p < 0.05]. Conclusion: The proposed protocol can facilitate improvements in upper extremity motor abilities in severe chronic stroke patients and is more beneficial than the protocol with FES therapy alone. Our results showed efficacy of the new paradigm with combined intervention in both the central nervous system and the peripheral nervous system.

TRIAL REGISTRATION: ChiCTR-ICR-15006108.

Original languageEnglish
Article number233
Pages (from-to)1-11
Number of pages11
JournalFrontiers in Human Neuroscience
Volume12
DOIs
Publication statusPublished - 19 Jun 2018

Keywords

  • Functional electrical stimulation
  • Homeostatic mechanism
  • Stroke
  • Transcranial direct current stimulation
  • Upper limb rehabilitation

ASJC Scopus subject areas

  • Neuropsychology and Physiological Psychology
  • Neurology
  • Psychiatry and Mental health
  • Biological Psychiatry
  • Behavioral Neuroscience

Cite this

Using tDCS as an Add-On Treatment Prior to FES Therapy in Improving Upper Limb Function in Severe Chronic Stroke Patients : A Randomized Controlled Study. / Shaheiwola, Nuerjiayi; Zhang, Bin; Jia, Jie; Zhang, Dingguo.

In: Frontiers in Human Neuroscience, Vol. 12, 233, 19.06.2018, p. 1-11.

Research output: Contribution to journalArticle

@article{b4e4de171e454216b937dac5bc2427ca,
title = "Using tDCS as an Add-On Treatment Prior to FES Therapy in Improving Upper Limb Function in Severe Chronic Stroke Patients: A Randomized Controlled Study",
abstract = "Background: Upper limb function recovery is of vital importance for stroke patients. However, it is difficult to get ideal recovery, especially for patients with severe chronic stroke. As the first randomized controlled long-term trial combining bilateral transcranial direct current stimulation (tDCS) and functional electrical stimulation (FES) therapy, this study examined the efficacy of a novel protocol that included applying tDCS as an add-on treatment prior to FES therapy over the course of a 4-week program. Methods: Thirty subjects with severe chronic stroke were randomized to either Group A (active tDCS+FES) ( N = 15) or Group B (sham tDCS+FES) ( N = 15). Five assessments including 3 behavioral outcome measurement scales [the Fugl-Meyer scale (cFMA), the Wolf motor function test (WMFT) and the modified Ashworth scale (MAS)], the surface electromyography (sEMG) evaluation and the transcranial magnetic stimulation (TMS) assessment were performed to evaluate subjects before and after the overall therapy. Results: In Group A, the combined protocol was well tolerated by all patients and induced significant improvements in upper extremity motor abilities in terms of the assessments of cFMA [ t (14) = -5.658, p < 0.05], WMFT [ t (14) = -3.746, p < 0.05], MAS [ t (14) = 5.236, p < 0.05], sEMG and TMS. The results of between-group comparisons showed there was a significant difference between Group A and Group B in terms of the assessments of cFMA [ t (28) = 2.223, p < 0.05], WMFT [ t (28) = -2.152, p < 0.05] and sEMG [ F (1, 196) = 0.918, p < 0.05]. Conclusion: The proposed protocol can facilitate improvements in upper extremity motor abilities in severe chronic stroke patients and is more beneficial than the protocol with FES therapy alone. Our results showed efficacy of the new paradigm with combined intervention in both the central nervous system and the peripheral nervous system. TRIAL REGISTRATION: ChiCTR-ICR-15006108.",
keywords = "Functional electrical stimulation, Homeostatic mechanism, Stroke, Transcranial direct current stimulation, Upper limb rehabilitation",
author = "Nuerjiayi Shaheiwola and Bin Zhang and Jie Jia and Dingguo Zhang",
year = "2018",
month = "6",
day = "19",
doi = "10.3389/fnhum.2018.00233",
language = "English",
volume = "12",
pages = "1--11",
journal = "Frontiers in Human Neuroscience",
issn = "1662-5161",
publisher = "Frontiers Media S.A.",

}

TY - JOUR

T1 - Using tDCS as an Add-On Treatment Prior to FES Therapy in Improving Upper Limb Function in Severe Chronic Stroke Patients

T2 - A Randomized Controlled Study

AU - Shaheiwola, Nuerjiayi

AU - Zhang, Bin

AU - Jia, Jie

AU - Zhang, Dingguo

PY - 2018/6/19

Y1 - 2018/6/19

N2 - Background: Upper limb function recovery is of vital importance for stroke patients. However, it is difficult to get ideal recovery, especially for patients with severe chronic stroke. As the first randomized controlled long-term trial combining bilateral transcranial direct current stimulation (tDCS) and functional electrical stimulation (FES) therapy, this study examined the efficacy of a novel protocol that included applying tDCS as an add-on treatment prior to FES therapy over the course of a 4-week program. Methods: Thirty subjects with severe chronic stroke were randomized to either Group A (active tDCS+FES) ( N = 15) or Group B (sham tDCS+FES) ( N = 15). Five assessments including 3 behavioral outcome measurement scales [the Fugl-Meyer scale (cFMA), the Wolf motor function test (WMFT) and the modified Ashworth scale (MAS)], the surface electromyography (sEMG) evaluation and the transcranial magnetic stimulation (TMS) assessment were performed to evaluate subjects before and after the overall therapy. Results: In Group A, the combined protocol was well tolerated by all patients and induced significant improvements in upper extremity motor abilities in terms of the assessments of cFMA [ t (14) = -5.658, p < 0.05], WMFT [ t (14) = -3.746, p < 0.05], MAS [ t (14) = 5.236, p < 0.05], sEMG and TMS. The results of between-group comparisons showed there was a significant difference between Group A and Group B in terms of the assessments of cFMA [ t (28) = 2.223, p < 0.05], WMFT [ t (28) = -2.152, p < 0.05] and sEMG [ F (1, 196) = 0.918, p < 0.05]. Conclusion: The proposed protocol can facilitate improvements in upper extremity motor abilities in severe chronic stroke patients and is more beneficial than the protocol with FES therapy alone. Our results showed efficacy of the new paradigm with combined intervention in both the central nervous system and the peripheral nervous system. TRIAL REGISTRATION: ChiCTR-ICR-15006108.

AB - Background: Upper limb function recovery is of vital importance for stroke patients. However, it is difficult to get ideal recovery, especially for patients with severe chronic stroke. As the first randomized controlled long-term trial combining bilateral transcranial direct current stimulation (tDCS) and functional electrical stimulation (FES) therapy, this study examined the efficacy of a novel protocol that included applying tDCS as an add-on treatment prior to FES therapy over the course of a 4-week program. Methods: Thirty subjects with severe chronic stroke were randomized to either Group A (active tDCS+FES) ( N = 15) or Group B (sham tDCS+FES) ( N = 15). Five assessments including 3 behavioral outcome measurement scales [the Fugl-Meyer scale (cFMA), the Wolf motor function test (WMFT) and the modified Ashworth scale (MAS)], the surface electromyography (sEMG) evaluation and the transcranial magnetic stimulation (TMS) assessment were performed to evaluate subjects before and after the overall therapy. Results: In Group A, the combined protocol was well tolerated by all patients and induced significant improvements in upper extremity motor abilities in terms of the assessments of cFMA [ t (14) = -5.658, p < 0.05], WMFT [ t (14) = -3.746, p < 0.05], MAS [ t (14) = 5.236, p < 0.05], sEMG and TMS. The results of between-group comparisons showed there was a significant difference between Group A and Group B in terms of the assessments of cFMA [ t (28) = 2.223, p < 0.05], WMFT [ t (28) = -2.152, p < 0.05] and sEMG [ F (1, 196) = 0.918, p < 0.05]. Conclusion: The proposed protocol can facilitate improvements in upper extremity motor abilities in severe chronic stroke patients and is more beneficial than the protocol with FES therapy alone. Our results showed efficacy of the new paradigm with combined intervention in both the central nervous system and the peripheral nervous system. TRIAL REGISTRATION: ChiCTR-ICR-15006108.

KW - Functional electrical stimulation

KW - Homeostatic mechanism

KW - Stroke

KW - Transcranial direct current stimulation

KW - Upper limb rehabilitation

UR - http://www.scopus.com/inward/record.url?scp=85054786096&partnerID=8YFLogxK

U2 - 10.3389/fnhum.2018.00233

DO - 10.3389/fnhum.2018.00233

M3 - Article

VL - 12

SP - 1

EP - 11

JO - Frontiers in Human Neuroscience

JF - Frontiers in Human Neuroscience

SN - 1662-5161

M1 - 233

ER -